type here...

CATEGORIES

Pharmaceutics

LATEST

1...891011Page 9 of 11

TRENDING

EDITORS CHOICE

Does Pharma Need Independent DNA Oversight?

Robert Turner, Founding Editor -
Our survival as a species could be placed in jeopardy if we don't begin to police treatments that place our DNA in harms way. Oversight is needed.

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Medika Life -
FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

Medika Life -
Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics

Lilly commits Insulin Value Program, With $35 Copay Card

Medika Life -
Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of Lilly insulins for $35 through this program.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories